**About the Editors**

**Rob W.J. Collin** Following the completion of his MSc studies in Chemistry, Dr. Collin obtained his Ph.D. studying the physiological role of proteins involved in Alzheimer's disease. Thereafter, he moved to the field of Human Genetics, where he first was involved in identifying the genetic causes of inherited hearing loss and, later, visual impairment. Intrigued by the upcoming potential of genetic therapies to treat these diseases, Dr. Collin shifted gears and built his own group around the topic of developing novel therapeutic strategies for inherited retinal diseases. Dr. Collin is currently an Associate Professor on "Molecular therapies for eye diseases" at the Department of Human Genetics of the Radboudumc.

**Alejandro Garanto** studied Biology at the University of Barcelona. Subsequently, he enrolled in the Ph.D. program of the Department of Genetics to study the function of a frequently mutated gene associated with inherited retinal disease. After the completion of his PhD, he worked on the exciting topic of deubiquitinating enzymes and their role in the retinal fate. In 2012, he moved to Nijmegen and joined the group of Dr. Collin at the Radboudumc as a postdoc. Since then, he has focused his scientific career on the development of novel therapeutic interventions for inherited retinal disease. Currently, Dr. Garanto is an Assistant Professor leading the "DNA and RNA editing for inherited retinal diseases" group at the Department of Human Genetics of the Radboudumc.
